B C J M Fauser

Author PubWeight™ 81.05‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod 2011 5.49
2 Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve. Hum Reprod 2002 3.59
3 Fertility and ageing. Hum Reprod Update 2005 2.68
4 Why do couples drop-out from IVF treatment? A prospective cohort study. Hum Reprod 2008 2.32
5 A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update 2006 2.26
6 Conception to ongoing pregnancy: the 'black box' of early pregnancy loss. Hum Reprod Update 2002 2.08
7 Economic evaluation of the administration of follitropin-beta with a pen device. Reprod Biomed Online 2005 1.99
8 PCOS according to the Rotterdam consensus criteria: Change in prevalence among WHO-II anovulation and association with metabolic factors. BJOG 2006 1.77
9 A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome. Hum Reprod Update 2005 1.63
10 A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol. Hum Reprod 2009 1.58
11 Preimplantation genetic screening reveals a high incidence of aneuploidy and mosaicism in embryos from young women undergoing IVF. Hum Reprod 2005 1.58
12 Optimum number of oocytes for a successful first IVF treatment cycle. Reprod Biomed Online 2006 1.53
13 Mild ovarian stimulation for IVF. Hum Reprod Update 2008 1.48
14 Testosterone concentrations, using different assays, in different types of ovarian insufficiency: a systematic review and meta-analysis. Hum Reprod Update 2012 1.48
15 [Pregnancy at a later age with the help of oocyte donation]. Ned Tijdschr Geneeskd 2006 1.38
16 Serum anti-müllerian hormone levels in healthy females: a nomogram ranging from infancy to adulthood. J Clin Endocrinol Metab 2012 1.35
17 Functional genetic polymorphisms and female reproductive disorders: Part I: Polycystic ovary syndrome and ovarian response. Hum Reprod Update 2008 1.30
18 The clinical significance of the retrieval of a low number of oocytes following mild ovarian stimulation for IVF: a meta-analysis. Hum Reprod Update 2008 1.26
19 The role of the endometrium and embryo in human implantation. Hum Reprod Update 2007 1.24
20 The number of antral follicles in normal women with proven fertility is the best reflection of reproductive age. Hum Reprod 2003 1.23
21 Low negative affect prior to treatment is associated with a decreased chance of live birth from a first IVF cycle. Hum Reprod 2007 1.17
22 Genetic polymorphisms of GnRH and gonadotrophic hormone receptors affect the phenotype of polycystic ovary syndrome. Hum Reprod 2009 1.15
23 The ISMAAR proposal on terminology for ovarian stimulation for IVF. Hum Reprod 2007 1.15
24 The psychological impact of IVF failure after two or more cycles of IVF with a mild versus standard treatment strategy. Hum Reprod 2007 1.08
25 Functional genetic polymorphisms and female reproductive disorders: part II--endometriosis. Hum Reprod Update 2008 1.07
26 Approaches to improve the diagnosis and management of infertility. Hum Reprod Update 2009 1.04
27 What is the most relevant standard of success in assisted reproduction? The next step to improving outcomes of IVF: consider the whole treatment. Hum Reprod 2004 1.01
28 A prospective randomized comparison of sequential versus monoculture systems for in-vitro human blastocyst development. Hum Reprod 2002 1.01
29 Current value of preimplantation genetic aneuploidy screening in IVF. Hum Reprod Update 2006 1.01
30 Endometrial secretion analysis identifies a cytokine profile predictive of pregnancy in IVF. Hum Reprod 2009 1.00
31 Fluorescence in situ hybridization analysis of two blastomeres from day 3 frozen-thawed embryos followed by analysis of the remaining embryo on day 5. Hum Reprod 2004 0.98
32 Comparison of the phenotype of Chinese versus Dutch Caucasian women presenting with polycystic ovary syndrome and oligo/amenorrhoea. Hum Reprod 2012 0.97
33 Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteria. Hum Reprod 2008 0.96
34 Contemporary genetic technologies and female reproduction. Hum Reprod Update 2011 0.95
35 Residual ovarian activity during oral steroid contraception. Hum Reprod Update 2002 0.93
36 FISH analysis of 15 chromosomes in human day 4 and 5 preimplantation embryos: the added value of extended aneuploidy detection. Prenat Diagn 2007 0.89
37 Diagnostic criteria for polycystic ovarian syndrome. Endocrine 2006 0.87
38 Effectiveness of a psychosocial counselling intervention for first-time IVF couples: a randomized controlled trial. Hum Reprod 2005 0.87
39 Mild stimulation in in vitro fertilization. Ann N Y Acad Sci 2003 0.87
40 Clinical outcomes in relation to the daily dose of recombinant follicle-stimulating hormone for ovarian stimulation in in vitro fertilization in presumed normal responders younger than 39 years: a meta-analysis. Hum Reprod Update 2010 0.86
41 Characteristics of the best prognostic evidence: an example on prediction of outcome after clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. Semin Reprod Med 2003 0.86
42 Sex hormone-binding globulin concentrations before conception as a predictor for gestational diabetes in women with polycystic ovary syndrome. Hum Reprod 2010 0.85
43 Fertility and ovarian function in high-dose estrogen-treated tall women. J Clin Endocrinol Metab 2011 0.85
44 Ovarian reserve. Semin Reprod Med 2005 0.85
45 Genetic polymorphisms of the glucocorticoid receptor may affect the phenotype of women with anovulatory polycystic ovary syndrome. Hum Reprod 2011 0.84
46 Predictors of low response to mild ovarian stimulation initiated on cycle day 5 for IVF. Hum Reprod 2007 0.84
47 The association of CGG repeats in the FMR1 gene and timing of natural menopause. Hum Reprod 2012 0.84
48 Endometrial secretion aspiration prior to embryo transfer does not reduce implantation rates. Reprod Biomed Online 2003 0.84
49 Cardiovascular and metabolic characteristics of infertile Chinese women with PCOS diagnosed according to the Rotterdam consensus criteria. Reprod Biomed Online 2010 0.84
50 The feasibility of a less invasive method to assess endometrial maturation--comparison of simultaneously obtained uterine secretion and tissue biopsy. BJOG 2009 0.84
51 Preconception predictors of gestational diabetes: a multicentre prospective cohort study on the predominant complication of pregnancy in polycystic ovary syndrome. Hum Reprod 2014 0.83
52 Gonadotrophins in ovulation induction. Reprod Biomed Online 2005 0.83
53 Cardiometabolic abnormalities in the polycystic ovary syndrome: pharmacotherapeutic insights. Pharmacol Ther 2008 0.83
54 The psychological impact of mild ovarian stimulation combined with single embryo transfer compared with conventional IVF. Hum Reprod 2005 0.83
55 Is there a future for ovulation induction in the current era of assisted reproduction? Hum Reprod 2003 0.83
56 Impact of ovarian stimulation on mid-luteal endometrial tissue and secretion markers of receptivity. Reprod Biomed Online 2008 0.82
57 Comparison of early versus late initiation of GnRH antagonist co-treatment for controlled ovarian stimulation in IVF: a randomized controlled trial. Hum Reprod 2013 0.82
58 The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis. Hum Reprod Update 2013 0.82
59 The added value of embryo cryopreservation to cumulative ongoing pregnancy rates per IVF treatment: is cryopreservation worth the effort? J Assist Reprod Genet 2002 0.81
60 Environmental and developmental origins of ovarian reserve. Hum Reprod Update 2013 0.81
61 ART: iatrogenic multiple pregnancy? Best Pract Res Clin Obstet Gynaecol 2006 0.78
62 Observer agreement in the evaluation of the uterine cavity by hysteroscopy prior to in vitro fertilization. Hum Reprod 2011 0.78
63 Ovarian stimulation for IVF and endometrial receptivity--the missing link. Reprod Biomed Online 2002 0.77
64 The impact of self-reported ethnicity versus genetic ancestry on phenotypic characteristics of polycystic ovary syndrome (PCOS). J Clin Endocrinol Metab 2014 0.77
65 Cancer and fertility: strategies to preserve fertility. Reprod Biomed Online 2010 0.77
66 LH suppression following different low doses of the GnRH antagonist ganirelix in polycystic ovary syndrome. J Endocrinol Invest 2005 0.77
67 FSH and ovarian response: spontaneous recovery of pituitary-ovarian activity during the pill-free period vs. exogenous recombinant FSH during high-dose combined oral contraceptives. Clin Endocrinol (Oxf) 2002 0.76
68 Inhibins and adult ovarian function. Mol Cell Endocrinol 2004 0.76
69 Predicting pregnancy in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2009 0.75
70 Building on solid foundations: the third editor-in-chief of Human Reproduction Update takes office. Hum Reprod Update 2006 0.75
71 Child development and quality of parenting in lesbian families: no psychosocial indications for a-priori withholding of infertility treatment. A systematic review. Hum Reprod Update 2002 0.75
72 [Reduction of patient discomfort, risks and costs, but not pregnancies, by a mild strategy for in-vitro fertilisation]. Ned Tijdschr Geneeskd 2008 0.75
73 Ovarian stimulation for IVF: mild approaches. Methods Mol Biol 2014 0.75
74 Individualized vaginal bleeding experience of women with uterine fibroids in the PEARL I randomized controlled trial comparing the effects of ulipristal acetate or placebo. Hum Reprod 2014 0.75
75 RBM online: challenges ahead in scientific publishing. Reprod Biomed Online 2017 0.75
76 Comparison of different treatment strategies in IVF with cumulative live birth over a given period of time as the primary end-point: methodological considerations on a randomized controlled non-inferiority trial. Hum Reprod 2005 0.75